AstraZeneca (AZN) October calls active
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 4/25/2024
- Wall Street stocks fall as weak GDP growth spreads rate-cut gloom
- Q1 US GDP shows surprise slowing and uncomfortable inflation
- Alphabet (GOOGL) soars 16% on Q1 results beat, first-ever dividend
- Meta shares dip on softer Q2 revenue guidance, elevated AI spending plans
- Oil settles higher as weak U.S. economic growth offset by supply concerns
- IBM tumbles on soft Q1 revenue; announces HashiCorp $6.4bn acquisition
- Hasbro (HAS) brand strength sees earnings top expectations
- Meta Platforms (META) Tops Q1 EPS by 39c, Offers Guidance
- Seagate Technology (STX) Enters $600M Asset Purchase Agreement with Avago
- Rubrik (RBRK) Prices Upsized 23.5M Share IPO at $32/sh
- After-hours movers: Alphabet, Microsoft, Snap, Intel, and more
- Midday movers: Meta, IBM, Caterpillar fall; Chipotle rises
- After-hours movers: Meta, Ford, IBM, ServiceNow and more
- Midday movers: Tesla, Boeing rise; Uber, Old Dominion Freight fall
- After-hours movers: Tesla, Texas Instruments, Seagate, Visa and more
AstraZeneca (AZN) Announces FDA Acceptance of Sodium Zirconium Cyclosilicate NDA Resubmission
October 18, 2016 7:51 AM EDTAstraZeneca (NYSE: AZN) announced that the US Food and Drug Administration (FDA) has accepted a complete re-submission of a New Drug Application (NDA) for sodium zirconium cyclosilicate (ZS-9), a potential new medicine for the treatment of hyperkalaemia (high potassium level in the blood serum) by ZS Pharma, a... More
AstraZeneca (AZN) Gains on Novartis (NVS) Chatter
October 17, 2016 11:06 AM EDTUpside in AstraZeneca (NYSE: AZN) is being attributed to a vague rumor that Novartis AG (NYSE: NVS) is looking to sell its 33.3% stake in Roche to make a cash bid for AstraZeneca.
AstraZeneca declined to comment on the speculation.
Shares of AZN are up 1.1%.
... More
